Individualized Choices in Antiretroviral Therapy: Present and Future

Listen as expert faculty review the latest data and guidelines on patient-centered ART selection for treatment-naive and virologically suppressed patients. Topics include assessing treatment options; individualizing ART for women of childbearing potential and during pregnancy, patients with OIs, and during the COVID-19 pandemic; and new data on investigational ART strategies.

Jean-Michel Molina, MD, PhD Cristina Mussini, MD Chloe Orkin, MBChB, FRCP, MD Released: December 21, 2021

Here’s why patients need to be placed front and center when choosing antiretroviral therapy.

Silvia Petretti Released: October 22, 2021

Here’s why I think the 3 most essential aspects when switching ART are treatment history, genetic barrier to resistance, and hearing what your patient is telling you.

Chloe Orkin, MBChB, FRCP, MD Released: November 24, 2021

Here are my thoughts on how the emergence of long-acting ART reflects the continued evolution of HIV treatment to better meet the broad needs of our patients and what ongoing research efforts may bring about for future long-acting ART options.

Jean-Michel Molina, MD, PhD Released: November 30, 2021

How soon should ART be initiated in patients who present with opportunistic infections, and what is the best regimen? In this commentary, I share my approach to starting ART in patients with advanced HIV and opportunistic infections.

Cristina Mussini, MD Released: December 13, 2021

Expert-authored slides covering the latest data and guidelines on patient-centered ART selection for treatment-naive and virologically suppressed patients. Topics include assessing treatment options, individualizing ART for women of childbearing potential and during pregnancy, patients with OIs, and during the COVID-19 pandemic, as well as new data on investigational ART strategies.

Jean-Michel Molina, MD, PhD Cristina Mussini, MD Chloe Orkin, MBChB, FRCP, MD Released: November 5, 2021

Hear insights from 3 faculty experts as they present emerging data and guidelines and engage in discussion on patient-centered ART selection for people with HIV.

Chloe Orkin, MBChB, FRCP, MD
Program Director Jean-Michel Molina, MD, PhD Cristina Mussini, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits™ Registered Nurses: 1.25 Nursing contact hours Pharmacists: 1.25 contact hours (0.125 CEUs) Released: December 29, 2021 Expired: December 28, 2022

Overview of Current Patient-Centered ART

Putting Individualized Care into Practice

Future ART: Closing the Remaining Gaps